LUMINEX CORP
LUMINEX CORP
Share · US55027E1029 · LMNX · 936597 (XNAS)
Overview Financial Indicators
No Price
n/a

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
- - - - 0,00 % 0,00 % 24,80 %

Company Profile for LUMINEX CORP Share

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; ARIES system, a sample to answer real-time PCR platform; ARIES M1 system, a single-module version of the ARIES System; VERIGENE system, a semi-automated, multiplex, molecular analysis system for the clinical diagnostics market; FlowSight Imaging Flow cytometer; ImageStream System; CellStream Flow Cytometer; Guava easyCyte line; and Muse Cell Analyzer. The company also provides MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; SYNCT data management software solutions; TDAS, an analysis program designed for development and optimization of nucleic acid assays; IDEAS, an image analysis software; and xTAG assays and products to identify the causative agent for respiratory and gastrointestinal infections, as well as IVD kits for cystic fibrosis genotyping and pharmacogenetic assays used to profile genetic mutations related to drug metabolism. In addition, it offers MultiCode assays and products comprising HSV 1&2 assays, and other products to detect infectious agents in clinical samples; ARIES cassettes that are self-contained assay consumables, such as ARIES HSV 1&2 assays, ARIES FLU A/B and RSV assays, ARIES group A strep assays, ARIES bordetella assays, ARIES GBS assay, and ARIES C. difficile assays; and VERIGENE test cartridges. The company serves pharmaceutical companies, clinical laboratories, and research and medical institutions. Luminex Corporation was founded in 1995 and is based in Austin, Texas.

Company Data

Name LUMINEX CORP
Company Luminex Corporation
Symbol LMNX
Website http://www.luminexcorp.com
Primary Exchange XNAS NASDAQ
WKN 936597
ISIN US55027E1029
Asset Class Share
Sector Healthcare
Industry Medical - Instruments & Supplies
CEO Mr. Nachum Shamir
Country United States of America
Currency USD
Employees 1,3 T
Address 12212 Technology Blvd, 512-219-8020, 78727 Austin
IPO Date 2000-03-30
Dividends from 'LUMINEX CORP'
Ex-Date Dividend per Share
16.06.2021 0,10 USD
24.03.2021 0,10 USD
22.12.2020 0,10 USD
23.09.2020 0,09 USD
17.06.2020 0,09 USD
18.03.2020 0,09 USD
18.12.2019 0,09 USD
25.09.2019 0,09 USD
19.06.2019 0,06 USD
20.03.2019 0,06 USD

Ticker Symbols

Name Symbol
NASDAQ LMNX

More Shares

Investors who LUMINEX CORP hold also have the following shares in their portfolio:
AMC NETWORKS INC - CLASS A
AMC NETWORKS INC - CLASS A Share
AMGEN INC
AMGEN INC Share
AUTODESK INC
AUTODESK INC Share
BGF-US GOV.MORTG.NAM.A2
BGF-US GOV.MORTG.NAM.A2 Fund
BIOGEN INC
BIOGEN INC Share
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Share
EBAY INC
EBAY INC Share
INTEL CORP
INTEL CORP Share
MICROSOFT CORP
MICROSOFT CORP Share
O'REILLY AUTOMOTIVE INC
O'REILLY AUTOMOTIVE INC Share
PFIZER IN.E. 23/43
PFIZER IN.E. 23/43 Bond
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Share
WILLDAN GROUP INC
WILLDAN GROUP INC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025